Inside the clinical trial practical experience with Xyrem in narcolepsy/cataplexy individuals at therapeutic doses, two patients documented anxiety and a person noted insomnia subsequent abrupt discontinuation at the termination in the clinical demo; in The 2 people with anxiousness, the frequency of cataplexy had improved markedly simultaneously.G